Publications by authors named "Michal Pirozynski"

Claim this Profile
I
Influence of Physicochemical Properties of Budesonide Micro-Suspensions on Their Expected Lung Delivery Using a Vibrating Mesh Nebulizer.
Katarzyna Dobrowolska, Andrzej Emeryk, Kamil Janeczek, Radosław Krzosa, Michał Pirożyński

Pharmaceutics· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchodilator response after two methods of salbutamol nebulization in asthmatic children.
Andrzej Emeryk, Kamil Janeczek, Ewa Markut-Miotła, Michał Pirożyński, Emil Florkiewicz

Postepy Dermatol Alergol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients.
David Michalovich, Noelia Rodriguez-Perez, Sylwia Smolinska, Michal Pirozynski, David Mayhew

Nat Commun· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gabapentin before laparoscopic sleeve gastrectomy reduces postoperative oxycodone consumption in obese patients: a randomized double-blind placebo-controlled trial.
Anna Rupniewska-Ladyko, Małgorzata Malec-Milewska, Ewa Kraszewska, Michal Pirozynski

Minerva Anestesiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
Jacek Roliński, Ewelina Grywalska, Aleksandra Pyzik, Michał Dzik, Violetta Opoka-Winiarska

BMC Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice.
Michał Pirożyński, Piotr Hantulik, Agnieszka Almgren-Rachtan, Jerzy Chudek

Adv Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrolide antibiotics in respiratory diseases. Recommendations of the Polish Expert Group - AD 2015.
Andrzej Emeryk, Henryk Mazurek, Michał Pirożyński, Janusz Klatka, Wojciech Służewski

Pneumonol Alergol Pol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New dry powder inhalers].
Andrzej Emeryk, Michał Pirożyński

Pneumonol Alergol Pol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation devices: from basic science to practical use, innovative vs generic products.
Michal Pirozynski, Tomasz R Sosnowski

Expert Opin Drug Deliv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].
Paweł Sliwiński, Ryszarda Chazan, Piotr Dąbrowiecki, Karina Jahnz-Różyk, Robert Mróz

Pneumonol Alergol Pol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Union pharmacovigilance capabilities: potential for the new legislation.
John Joseph Borg, Amy Tanti, Dimitrios Kouvelas, Calin Lungu, Michal Pirozynski

Ther Adv Drug Saf· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective.
John Joseph Borg, Paolo Tomasi, Luca Pani, George Aislaitner, Michal Pirozynski

Sci Pharm· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma.
Massimo Corradi, Henry Chrystyn, Borja G Cosio, Michal Pirozynski, Stelios Loukides

Expert Opin Drug Deliv· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
John-Joseph Borg, George Aislaitner, Michal Pirozynski, Stephen Mifsud

Drug Saf· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products.
John Joseph Borg, Jean-Louis Robert, George Wade, George Aislaitner, Michal Pirozynski

J Pharm Pharm Sci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The effect of fenspiride on the number of exacerbations and the time of first exacerbation in patients with chronic bronchitis].
Michał Pirozyński, Wojciech Skucha, Marek Słomiński, Elzbieta Chyczewska, Janusz Malinowski

Pol Merkur Lekarski· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and therapy of chronic obstructive pulmonary disease--recommendations of the Polish Phtisiopneumonology Society].
Jerzy Kozielski, Ryszard Chazan, Dorota Gorecka, Karina Jahnz-Rozyk, Wieslaw Jedrychowski, Michal Pirozynski

Pneumonol Alergol Pol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immunopathology of bronchial asthma and COPD].
Michał Pirozyński

Pneumonol Alergol Pol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis